Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $110,000 | 1 | 89.0% |
| Consulting Fee | $13,235 | 3 | 10.7% |
| Food and Beverage | $311.95 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $119,060 | 2 | $0 (2020) |
| Gilead Sciences, Inc. | $2,570 | 1 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $1,605 | 1 | $0 (2020) |
| Amgen Inc. | $131.09 | 1 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $118.38 | 1 | $0 (2024) |
| CTI BioPharma Corp. | $62.48 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.38 | 1 | JAZZ PHARMACEUTICALS INC. ($118.38) |
| 2023 | $62.48 | 1 | CTI BioPharma Corp. ($62.48) |
| 2022 | $131.09 | 1 | Amgen Inc. ($131.09) |
| 2021 | $2,570 | 1 | Gilead Sciences, Inc. ($2,570) |
| 2020 | $10,665 | 2 | AstraZeneca Pharmaceuticals LP ($9,060) |
| 2019 | $110,000 | 1 | AstraZeneca Pharmaceuticals LP ($110,000) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/08/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $118.38 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/15/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $62.48 | General |
| Category: Hematology | ||||||
| 04/29/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $131.09 | General |
| Category: Oncology | ||||||
| 08/31/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,570.00 | General |
| 12/18/2020 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological), DUPIXENT | Consulting Fee | Cash or cash equivalent | $1,605.00 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2020 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $9,060.00 | General |
| Category: Oncology | ||||||
| 01/07/2019 | AstraZeneca Pharmaceuticals LP | — | Grant | Cash or cash equivalent | $110,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 155 | 484 | $228,960 | $34,318 |
| 2022 | 6 | 106 | 181 | $114,510 | $19,746 |
| 2021 | 9 | 179 | 466 | $209,500 | $39,882 |
| 2020 | 4 | 57 | 137 | $66,190 | $8,734 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77301 | High precision radiation therapy planning | Facility | 2023 | 22 | 23 | $36,800 | $8,591 | 23.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 17 | 42 | $73,500 | $7,236 | 9.8% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 22 | 23 | $19,780 | $4,705 | 23.8% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 27 | 28 | $58,100 | $4,272 | 7.4% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 14 | 221 | $17,680 | $4,056 | 22.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 26 | 105 | $12,600 | $3,170 | 25.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 27 | 42 | $10,500 | $2,289 | 21.8% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 16 | 17 | $27,200 | $6,355 | 23.4% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 16 | 17 | $14,620 | $3,511 | 24.0% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 21 | 22 | $45,650 | $3,451 | 7.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 16 | $9,280 | $2,287 | 24.6% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 19 | 73 | $8,760 | $2,165 | 24.7% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 21 | 36 | $9,000 | $1,977 | 22.0% |
| 77301 | Management of modulation radiotherapy planning | Facility | 2021 | 24 | 26 | $41,600 | $9,718 | 23.4% |
| 77435 | Stereotactic radiation treatment management of 1 or more lesions using imaging guidance, per treatment course | Facility | 2021 | 13 | 14 | $34,720 | $8,313 | 23.9% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2021 | 24 | 26 | $22,360 | $5,299 | 23.7% |
| 77263 | Management of radiation therapy, complex | Facility | 2021 | 26 | 28 | $58,100 | $4,361 | 7.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2021 | 28 | 117 | $14,820 | $3,450 | 23.3% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2021 | 16 | 76 | $12,920 | $3,083 | 23.9% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2021 | 11 | 126 | $10,080 | $2,305 | 22.9% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2021 | 26 | 42 | $10,500 | $2,295 | 21.9% |
| 77293 | Respiratory motion management simulation | Facility | 2021 | 11 | 11 | $4,400 | $1,059 | 24.1% |
| 77263 | Management of radiation therapy, complex | Facility | 2020 | 16 | 18 | $37,350 | $2,826 | 7.6% |
| 77300 | Calculation of radiation therapy dose | Facility | 2020 | 14 | 74 | $11,630 | $2,203 | 18.9% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2020 | 16 | 34 | $8,080 | $1,899 | 23.5% |
About Robert Samstein, MD, PHD
Robert Samstein, MD, PHD is a Radiation Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134547136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Samstein, MD, PHD has received a total of $123,547 in payments from pharmaceutical and medical device companies, with $118.38 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Grant" ($110,000).
As a Medicare-enrolled provider, Samstein has provided services to 497 Medicare beneficiaries, totaling 1,268 services with total Medicare billing of $102,680. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location New York, NY
- Active Since 04/07/2014
- Last Updated 11/15/2023
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1134547136
Products in Payments
- TAGRISSO (Drug) $9,060
- LIBTAYO (Biological) $1,605
- LUMAKRAS (Drug) $131.09
- ZEPZELCA (Drug) $118.38
- Vonjo (Drug) $62.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in New York
Michael Zelefsky, Md, MD
Radiation Oncology — Payments: $1.3M
Nancy Lee, Md, MD
Radiation Oncology — Payments: $203,950
Charles Simone, Md, MD
Radiation Oncology — Payments: $134,853
Silvia Formenti, M.d, M.D
Radiation Oncology — Payments: $121,142
Christopher Crane, M.d, M.D
Radiation Oncology — Payments: $59,684
Yoshiya Yamada, Md, MD
Radiation Oncology — Payments: $50,019